The immunoregulation of mesenchymal stem cells plays a critical role in improving the prognosis of liver transplantation
The liver is supplied by a dual blood supply, including the portal venous system and the hepatic arterial system; thus, the liver organ is exposed to multiple gut microbial products, metabolic products, and toxins; is sensitive to extraneous pathogens; and can develop liver failure, liver cirrhosis...
Saved in:
| Published in: | Journal of translational medicine Vol. 17; no. 1; pp. 412 - 12 |
|---|---|
| Main Authors: | , |
| Format: | Journal Article |
| Language: | English |
| Published: |
London
BioMed Central
10.12.2019
BioMed Central Ltd Springer Nature B.V BMC |
| Subjects: | |
| ISSN: | 1479-5876, 1479-5876 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | The liver is supplied by a dual blood supply, including the portal venous system and the hepatic arterial system; thus, the liver organ is exposed to multiple gut microbial products, metabolic products, and toxins; is sensitive to extraneous pathogens; and can develop liver failure, liver cirrhosis and hepatocellular carcinoma (HCC) after short-term or long-term injury. Although liver transplantation (LT) serves as the only effective treatment for patients with end-stage liver diseases, it is not very popular because of the complications and low survival rates. Although the liver is generally termed an immune and tolerogenic organ with adaptive systems consisting of humoral immunity and cell-mediated immunity, a high rejection rate is still the main complication in patients with LT. Growing evidence has shown that mesenchymal stromal cell (MSC) transplantation could serve as an effective immunomodulatory strategy to induce tolerance in various immune-related disorders. MSCs are reported to inhibit the immune response from innate immune cells, including macrophages, dendritic cells (DCs), natural killer cells (NK cells), and natural killer T (NKT) cells, and that from adaptive immune cells, including T cells, B cells and other liver-specific immune cells, for the generation of a tolerogenic microenvironment. In this review, we summarized the relationship between LT and immunoregulation, and we focused on how to improve the effects of MSC transplantation to improve the prognosis of LT. Only after exhaustive clarification of the potential immunoregulatory mechanisms of MSCs in vitro and in vivo can we implement MSC protocols in routine clinical practice to improve LT outcome. |
|---|---|
| AbstractList | The liver is supplied by a dual blood supply, including the portal venous system and the hepatic arterial system; thus, the liver organ is exposed to multiple gut microbial products, metabolic products, and toxins; is sensitive to extraneous pathogens; and can develop liver failure, liver cirrhosis and hepatocellular carcinoma (HCC) after short-term or long-term injury. Although liver transplantation (LT) serves as the only effective treatment for patients with end-stage liver diseases, it is not very popular because of the complications and low survival rates. Although the liver is generally termed an immune and tolerogenic organ with adaptive systems consisting of humoral immunity and cell-mediated immunity, a high rejection rate is still the main complication in patients with LT. Growing evidence has shown that mesenchymal stromal cell (MSC) transplantation could serve as an effective immunomodulatory strategy to induce tolerance in various immune-related disorders. MSCs are reported to inhibit the immune response from innate immune cells, including macrophages, dendritic cells (DCs), natural killer cells (NK cells), and natural killer T (NKT) cells, and that from adaptive immune cells, including T cells, B cells and other liver-specific immune cells, for the generation of a tolerogenic microenvironment. In this review, we summarized the relationship between LT and immunoregulation, and we focused on how to improve the effects of MSC transplantation to improve the prognosis of LT. Only after exhaustive clarification of the potential immunoregulatory mechanisms of MSCs in vitro and in vivo can we implement MSC protocols in routine clinical practice to improve LT outcome. Keywords: Mesenchymal stromal cell, Immunoregulation, Liver transplantation, Rejection, Prognosis The liver is supplied by a dual blood supply, including the portal venous system and the hepatic arterial system; thus, the liver organ is exposed to multiple gut microbial products, metabolic products, and toxins; is sensitive to extraneous pathogens; and can develop liver failure, liver cirrhosis and hepatocellular carcinoma (HCC) after short-term or long-term injury. Although liver transplantation (LT) serves as the only effective treatment for patients with end-stage liver diseases, it is not very popular because of the complications and low survival rates. Although the liver is generally termed an immune and tolerogenic organ with adaptive systems consisting of humoral immunity and cell-mediated immunity, a high rejection rate is still the main complication in patients with LT. Growing evidence has shown that mesenchymal stromal cell (MSC) transplantation could serve as an effective immunomodulatory strategy to induce tolerance in various immune-related disorders. MSCs are reported to inhibit the immune response from innate immune cells, including macrophages, dendritic cells (DCs), natural killer cells (NK cells), and natural killer T (NKT) cells, and that from adaptive immune cells, including T cells, B cells and other liver-specific immune cells, for the generation of a tolerogenic microenvironment. In this review, we summarized the relationship between LT and immunoregulation, and we focused on how to improve the effects of MSC transplantation to improve the prognosis of LT. Only after exhaustive clarification of the potential immunoregulatory mechanisms of MSCs in vitro and in vivo can we implement MSC protocols in routine clinical practice to improve LT outcome. Abstract The liver is supplied by a dual blood supply, including the portal venous system and the hepatic arterial system; thus, the liver organ is exposed to multiple gut microbial products, metabolic products, and toxins; is sensitive to extraneous pathogens; and can develop liver failure, liver cirrhosis and hepatocellular carcinoma (HCC) after short-term or long-term injury. Although liver transplantation (LT) serves as the only effective treatment for patients with end-stage liver diseases, it is not very popular because of the complications and low survival rates. Although the liver is generally termed an immune and tolerogenic organ with adaptive systems consisting of humoral immunity and cell-mediated immunity, a high rejection rate is still the main complication in patients with LT. Growing evidence has shown that mesenchymal stromal cell (MSC) transplantation could serve as an effective immunomodulatory strategy to induce tolerance in various immune-related disorders. MSCs are reported to inhibit the immune response from innate immune cells, including macrophages, dendritic cells (DCs), natural killer cells (NK cells), and natural killer T (NKT) cells, and that from adaptive immune cells, including T cells, B cells and other liver-specific immune cells, for the generation of a tolerogenic microenvironment. In this review, we summarized the relationship between LT and immunoregulation, and we focused on how to improve the effects of MSC transplantation to improve the prognosis of LT. Only after exhaustive clarification of the potential immunoregulatory mechanisms of MSCs in vitro and in vivo can we implement MSC protocols in routine clinical practice to improve LT outcome. The liver is supplied by a dual blood supply, including the portal venous system and the hepatic arterial system; thus, the liver organ is exposed to multiple gut microbial products, metabolic products, and toxins; is sensitive to extraneous pathogens; and can develop liver failure, liver cirrhosis and hepatocellular carcinoma (HCC) after short-term or long-term injury. Although liver transplantation (LT) serves as the only effective treatment for patients with end-stage liver diseases, it is not very popular because of the complications and low survival rates. Although the liver is generally termed an immune and tolerogenic organ with adaptive systems consisting of humoral immunity and cell-mediated immunity, a high rejection rate is still the main complication in patients with LT. Growing evidence has shown that mesenchymal stromal cell (MSC) transplantation could serve as an effective immunomodulatory strategy to induce tolerance in various immune-related disorders. MSCs are reported to inhibit the immune response from innate immune cells, including macrophages, dendritic cells (DCs), natural killer cells (NK cells), and natural killer T (NKT) cells, and that from adaptive immune cells, including T cells, B cells and other liver-specific immune cells, for the generation of a tolerogenic microenvironment. In this review, we summarized the relationship between LT and immunoregulation, and we focused on how to improve the effects of MSC transplantation to improve the prognosis of LT. Only after exhaustive clarification of the potential immunoregulatory mechanisms of MSCs in vitro and in vivo can we implement MSC protocols in routine clinical practice to improve LT outcome.The liver is supplied by a dual blood supply, including the portal venous system and the hepatic arterial system; thus, the liver organ is exposed to multiple gut microbial products, metabolic products, and toxins; is sensitive to extraneous pathogens; and can develop liver failure, liver cirrhosis and hepatocellular carcinoma (HCC) after short-term or long-term injury. Although liver transplantation (LT) serves as the only effective treatment for patients with end-stage liver diseases, it is not very popular because of the complications and low survival rates. Although the liver is generally termed an immune and tolerogenic organ with adaptive systems consisting of humoral immunity and cell-mediated immunity, a high rejection rate is still the main complication in patients with LT. Growing evidence has shown that mesenchymal stromal cell (MSC) transplantation could serve as an effective immunomodulatory strategy to induce tolerance in various immune-related disorders. MSCs are reported to inhibit the immune response from innate immune cells, including macrophages, dendritic cells (DCs), natural killer cells (NK cells), and natural killer T (NKT) cells, and that from adaptive immune cells, including T cells, B cells and other liver-specific immune cells, for the generation of a tolerogenic microenvironment. In this review, we summarized the relationship between LT and immunoregulation, and we focused on how to improve the effects of MSC transplantation to improve the prognosis of LT. Only after exhaustive clarification of the potential immunoregulatory mechanisms of MSCs in vitro and in vivo can we implement MSC protocols in routine clinical practice to improve LT outcome. |
| ArticleNumber | 412 |
| Audience | Academic |
| Author | Li, Lanjuan Hu, Chenxia |
| Author_xml | – sequence: 1 givenname: Chenxia surname: Hu fullname: Hu, Chenxia organization: Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, School of Medicine, Zhejiang University, National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University – sequence: 2 givenname: Lanjuan surname: Li fullname: Li, Lanjuan email: ljli@zju.edu.cn organization: Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, School of Medicine, Zhejiang University, National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31823784$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kktr3DAUhU1JaR7tH-iiGLrpxqketixtCiH0EQhkM3shy7JHgyxNJXvo_Ptcj5MmE0LQQhfpnE_cq3OenfjgTZZ9xugSY86-J0wEqwuERYEInqt32Rkua1FUvGYnz-rT7DylDUKkrErxITulmBNa8_Is-7dam9wOw-RDNP3k1GiDz0OXDyYZr9f7Qbk8jWbItXEu5Vun9ilXuY52tBruYnAA8MDYxrCzvs9HIELd-5BsmlHO7kzMx6h8ArsfD298zN53yiXz6WG_yFa_fq6u_xS3d79vrq9uC81QPRYtVSXVSNcaK4NZZRjlDVVdhRqBmBEGdRQLopnACGnKuGBIK9bgSlQtUfQiu1mwbVAbuY12UHEvg7LycBBiL1WETpyRRFRIIKx1yXkpatJ0CqsSZqyaCrV1BawfC2s7NYNptfHQkzuCHt94u5Z92EkmUIUoBcC3B0AMfyeTRjnYNM9VeROmJAklpSDwtwKkX19IN2GKHiY1qzgTNcf4SdUraMD6LsC7eobKK4YRRYBCoLp8RQWrNYPVkKnOwvmR4cvzRv93-BgbEPBFoGNIKZpOart8K5CtkxjJOaFySaiEhMpDQuXMJi-sj_Q3TXQxJRD73sSnabzhuge3w_g3 |
| CitedBy_id | crossref_primary_10_1007_s11010_024_05145_3 crossref_primary_10_33549_physiolres_934623 crossref_primary_10_3389_fimmu_2022_865888 crossref_primary_10_1007_s12015_025_10933_5 crossref_primary_10_1177_1759720X221100294 crossref_primary_10_1186_s43556_021_00067_8 crossref_primary_10_4252_wjsc_v13_i9_1349 crossref_primary_10_1038_s41392_024_01936_8 crossref_primary_10_1002_jbt_22881 crossref_primary_10_3389_fmed_2021_655268 crossref_primary_10_1016_j_lfs_2023_121618 crossref_primary_10_4252_wjsc_v12_i10_1184 crossref_primary_10_1002_cbf_4040 crossref_primary_10_3389_fcell_2025_1536566 crossref_primary_10_1155_2021_5513309 crossref_primary_10_1183_16000617_0042_2021 crossref_primary_10_3390_ijms22158121 crossref_primary_10_1016_j_trim_2022_101592 crossref_primary_10_3389_fbioe_2020_557652 crossref_primary_10_3389_fimmu_2023_1227756 crossref_primary_10_1016_j_colsurfb_2024_113942 crossref_primary_10_1016_j_ijbiomac_2023_126651 crossref_primary_10_1177_20587384211018389 crossref_primary_10_3389_fimmu_2023_1274982 crossref_primary_10_1007_s00109_020_02031_5 crossref_primary_10_3389_fimmu_2020_02155 crossref_primary_10_1016_j_jceh_2023_05_007 crossref_primary_10_1186_s13287_022_02734_1 crossref_primary_10_2147_JIR_S349572 crossref_primary_10_1186_s12964_023_01191_4 crossref_primary_10_1016_j_cej_2024_158313 crossref_primary_10_1002_wrna_1773 crossref_primary_10_29413_ABS_2025_10_1_3 crossref_primary_10_1002_cbin_11652 crossref_primary_10_1016_j_pharmthera_2021_108004 crossref_primary_10_1177_09636897251344851 crossref_primary_10_3389_fmicb_2024_1381401 |
| Cites_doi | 10.1002/hep.24755 10.1182/blood-2005-07-2775 10.1007/s12015-013-9430-y 10.1182/blood-2005-07-2657 10.1016/j.stem.2008.07.003 10.1111/j.1365-2249.2010.04256.x 10.1089/154732804323099190 10.1111/cei.12283 10.4254/wjh.v8.i3.148 10.1038/s41577-018-0034-2 10.1002/stem.2437 10.1016/j.jss.2013.02.009 10.3389/fgene.2017.00161 10.4172/2157-7633.1000166 10.1182/blood-2004-09-3696 10.1002/path.1711600308 10.1007/978-94-024-1170-6_1 10.1038/nri2858 10.1136/gutjnl-2015-309395 10.1016/j.trim.2018.08.004 10.1002/stem.503 10.3109/08820139.2011.607877 10.1634/stemcells.2004-0359 10.1016/j.jaut.2013.08.006 10.1186/s13287-016-0416-y 10.1182/blood-2002-07-2104 10.1155/2012/893026 10.1634/stemcells.2008-0687 10.3892/etm.2015.2551 10.1084/jem.20072195 10.1111/imm.12021 10.1016/j.trim.2015.07.006 10.4049/jimmunol.0902551 10.3390/ijms18071450 10.1038/sj.leu.2403871 10.1080/14653240600855905 10.5152/tjg.2018.17395 10.1038/nri3307 10.3324/haematol.11240 10.1016/j.transproceed.2009.08.072 10.1007/s00441-014-1956-z 10.3892/ijmm.2017.3121 10.1146/annurev-animal-031412-103651 10.1016/j.transproceed.2018.02.180 10.1038/nri3920 10.1111/j.1432-2277.2001.tb00052.x 10.1111/j.1365-2796.2007.01844.x 10.1038/leu.2014.225 10.1016/j.molimm.2016.10.004 10.1016/S0140-6736(79)92440-1 10.1038/cdd.2013.158 10.1038/ni.3341 10.1002/hep.23191 10.1002/hep.23043 10.1002/eji.200939782 10.1016/j.intimp.2017.04.009 10.1016/j.stem.2007.11.014 10.1038/emm.2013.135 10.3389/fimmu.2019.00093 10.1056/NEJM199806183382506 10.1007/s00109-019-01804-x 10.1038/mt.2011.189 10.1002/lt.23414 10.1038/cmi.2014.118 10.1002/lt.500010104 10.1016/j.cellimm.2016.12.006 10.1159/000369743 10.1002/sctm.17-0134 10.1016/S1995-7645(12)60184-9 10.12688/f1000research.11332.1 10.1038/82161 10.1016/S1499-3872(16)60085-1 10.1182/blood-2007-02-074997 10.1167/iovs.10-6334 10.1007/s00018-017-2473-5 10.1016/j.trim.2017.07.005 10.1038/jid.2009.30 10.3748/wjg.v23.i19.3449 10.1016/j.transproceed.2008.10.020 10.1111/j.1600-6143.2005.00995.x 10.1590/S1679-45082015RW3164 10.4049/jimmunol.177.6.3615 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2019 COPYRIGHT 2019 BioMed Central Ltd. 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2019 – notice: COPYRIGHT 2019 BioMed Central Ltd. – notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION NPM 3V. 7T5 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12967-019-02167-0 |
| DatabaseName | Springer Nature Link CrossRef PubMed ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database CrossRef MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: ProQuest Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1479-5876 |
| EndPage | 12 |
| ExternalDocumentID | oai_doaj_org_article_2950901cc4884972bfa1a4129ab50d75 PMC6905033 A610301890 31823784 10_1186_s12967_019_02167_0 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GrantInformation_xml | – fundername: Science Fund for Creative Research Groups of the National Natural Science Foundation of China grantid: 81121002 – fundername: National Natural Science Foundation of China grantid: 81700553 funderid: http://dx.doi.org/10.13039/501100001809 – fundername: China Postdoctoral Science Foundation grantid: 2017M183789 funderid: http://dx.doi.org/10.13039/501100002858 – fundername: ; grantid: 81121002 – fundername: ; grantid: 2017M183789 – fundername: ; grantid: 81700553 |
| GroupedDBID | --- 0R~ 29L 2WC 53G 5VS 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SBL SOJ TR2 TUS UKHRP WOQ WOW XSB ~8M AAYXX AFFHD CITATION -A0 3V. ACRMQ ADINQ ALIPV C24 NPM 7T5 7XB 8FK AZQEC DWQXO EJD H94 K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c607t-d3a43c0c7c1ae165e638b3af50b906e9e0f3192c69100c368960ca6b1595d2a3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 39 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000517754200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1479-5876 |
| IngestDate | Mon Nov 10 04:27:45 EST 2025 Tue Nov 04 02:01:14 EST 2025 Fri Sep 05 11:10:32 EDT 2025 Sun Oct 19 00:08:23 EDT 2025 Tue Nov 11 10:38:57 EST 2025 Tue Nov 04 18:05:25 EST 2025 Thu Jan 02 22:58:50 EST 2025 Tue Nov 18 20:37:31 EST 2025 Sat Nov 29 06:00:35 EST 2025 Sat Sep 06 07:28:41 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Rejection Mesenchymal stromal cell Prognosis Immunoregulation Liver transplantation |
| Language | English |
| License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c607t-d3a43c0c7c1ae165e638b3af50b906e9e0f3192c69100c368960ca6b1595d2a3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://doaj.org/article/2950901cc4884972bfa1a4129ab50d75 |
| PMID | 31823784 |
| PQID | 2328697811 |
| PQPubID | 43076 |
| PageCount | 12 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_2950901cc4884972bfa1a4129ab50d75 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6905033 proquest_miscellaneous_2324921189 proquest_journals_2328697811 gale_infotracmisc_A610301890 gale_infotracacademiconefile_A610301890 pubmed_primary_31823784 crossref_citationtrail_10_1186_s12967_019_02167_0 crossref_primary_10_1186_s12967_019_02167_0 springer_journals_10_1186_s12967_019_02167_0 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-12-10 |
| PublicationDateYYYYMMDD | 2019-12-10 |
| PublicationDate_xml | – month: 12 year: 2019 text: 2019-12-10 day: 10 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Journal of translational medicine |
| PublicationTitleAbbrev | J Transl Med |
| PublicationTitleAlternate | J Transl Med |
| PublicationYear | 2019 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | JG Casado (2167_CR50) 2013; 9 RY Calne (2167_CR3) 1979; 2 QZ Zhang (2167_CR69) 2010; 28 P Saas (2167_CR14) 2017; 6 D Parra (2167_CR25) 2013; 1 EG Perdiguero (2167_CR11) 2016; 17 RF Meirelles Junior (2167_CR1) 2015; 13 LE Nagy (2167_CR10) 2015; 37 A Limmer (2167_CR36) 2000; 6 Z Tu (2167_CR41) 2008; 205 V Borger (2167_CR79) 2017; 18 W Gao (2167_CR76) 2017; 45 AW Thomson (2167_CR27) 2010; 10 E Albano (2167_CR24) 2012; 2012 Y Yang (2167_CR73) 2016; 15 C Heerwagen (2167_CR29) 2001; 14 M Shi (2167_CR72) 2017; 6 Y Wang (2167_CR74) 2009; 41 C Rastellini (2167_CR45) 1995; 60 MJ Crop (2167_CR61) 2010; 162 HF Huang (2167_CR40) 2012; 59 E Breous (2167_CR44) 2009; 50 GM Spaggiari (2167_CR47) 2008; 111 W Liu (2167_CR52) 2015; 35 DI Cho (2167_CR68) 2014; 46 J Gong (2167_CR42) 2017; 48 M Crisan (2167_CR6) 2008; 3 Y Peng (2167_CR67) 2015; 29 J Niu (2167_CR85) 2014; 176 MH Sayegh (2167_CR30) 1998; 338 F Fatima (2167_CR80) 2017; 8 MS Ascha (2167_CR4) 2016; 8 C Prevosto (2167_CR63) 2007; 92 ME Reinders (2167_CR18) 2014; 4 KM Jamil (2167_CR33) 2017; 66 GM Spaggiari (2167_CR49) 2006; 107 ZF Hong (2167_CR83) 2009; 41 C Hu (2167_CR8) 2019; 97 ZG Zhao (2167_CR56) 2012; 41 M Krampera (2167_CR7) 2003; 101 G Ren (2167_CR60) 2008; 2 Y Tian (2167_CR70) 2016; 7 NM Chapman (2167_CR21) 2017; 1011 H Sasajima (2167_CR82) 2018; 50 X Jiang (2167_CR64) 2014; 358 C Ju (2167_CR13) 2015; 37 B Wu (2167_CR89) 2016; 2016 A Balato (2167_CR19) 2009; 129 J Tang (2167_CR84) 2016; 34 CM Crosby (2167_CR20) 2018; 18 N Li (2167_CR22) 2017; 74 I Prigione (2167_CR51) 2009; 27 LR Fisher (2167_CR2) 1995; 1 S Glennie (2167_CR57) 2005; 105 JJ van den Oord (2167_CR16) 1990; 160 N Kruse (2167_CR38) 2009; 50 J Plumas (2167_CR59) 2005; 19 R Wang (2167_CR87) 2017; 40 K Le Blanc (2167_CR9) 2007; 262 M Francois (2167_CR53) 2012; 20 Q Chen (2167_CR77) 2018; 51 S Ma (2167_CR62) 2014; 21 Q Liu (2167_CR58) 2015; 12 R Garcia de la Garza (2167_CR32) 2015; 33 W He (2167_CR46) 2016; 79 Z Du (2167_CR78) 2013; 183 Y Lavin (2167_CR12) 2015; 15 H Obara (2167_CR34) 2005; 5 A Corcione (2167_CR66) 2006; 107 R Kushwah (2167_CR17) 2010; 40 PA Sotiropoulou (2167_CR48) 2006; 24 ZY Shen (2167_CR86) 2017; 313 MH Karimi (2167_CR39) 2015; 6 X Xia (2167_CR81) 2012; 18 P Invernizzi (2167_CR28) 2013; 46 H Yu (2167_CR15) 2019; 10 HY Kim (2167_CR31) 2013; 138 L Russo (2167_CR35) 2012; 55 D Tokita (2167_CR37) 2006; 177 GS Chen (2167_CR43) 2012; 5 M Dominici (2167_CR5) 2006; 8 M Yang (2167_CR26) 2010; 184 W Zhang (2167_CR54) 2004; 13 Z Sun (2167_CR75) 2015; 10 GM Spaggiari (2167_CR55) 2013; 130 X Zhang (2167_CR65) 2011; 52 SM Kaech (2167_CR23) 2012; 12 J Niu (2167_CR71) 2018; 29 L Yang (2167_CR88) 2017; 23 |
| References_xml | – volume: 55 start-page: 921 issue: 3 year: 2012 ident: 2167_CR35 publication-title: Hepatology doi: 10.1002/hep.24755 – volume: 107 start-page: 1484 issue: 4 year: 2006 ident: 2167_CR49 publication-title: Blood doi: 10.1182/blood-2005-07-2775 – volume: 130 start-page: 199 year: 2013 ident: 2167_CR55 publication-title: Adv Biochem Eng Biotechnol – volume: 9 start-page: 184 issue: 2 year: 2013 ident: 2167_CR50 publication-title: Stem Cell Rev doi: 10.1007/s12015-013-9430-y – volume: 107 start-page: 367 issue: 1 year: 2006 ident: 2167_CR66 publication-title: Blood doi: 10.1182/blood-2005-07-2657 – volume: 3 start-page: 301 issue: 3 year: 2008 ident: 2167_CR6 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2008.07.003 – volume: 162 start-page: 474 issue: 3 year: 2010 ident: 2167_CR61 publication-title: Clin Exp Immunol doi: 10.1111/j.1365-2249.2010.04256.x – volume: 13 start-page: 263 issue: 3 year: 2004 ident: 2167_CR54 publication-title: Stem Cells Dev doi: 10.1089/154732804323099190 – volume: 176 start-page: 473 issue: 3 year: 2014 ident: 2167_CR85 publication-title: Clin Exp Immunol doi: 10.1111/cei.12283 – volume: 8 start-page: 148 issue: 3 year: 2016 ident: 2167_CR4 publication-title: World J Hepatol doi: 10.4254/wjh.v8.i3.148 – volume: 18 start-page: 559 issue: 9 year: 2018 ident: 2167_CR20 publication-title: Nat Rev Immunol doi: 10.1038/s41577-018-0034-2 – volume: 34 start-page: 2681 issue: 11 year: 2016 ident: 2167_CR84 publication-title: Stem Cells doi: 10.1002/stem.2437 – volume: 183 start-page: 907 issue: 2 year: 2013 ident: 2167_CR78 publication-title: J Surg Res doi: 10.1016/j.jss.2013.02.009 – volume: 8 start-page: 161 year: 2017 ident: 2167_CR80 publication-title: Front Genet doi: 10.3389/fgene.2017.00161 – volume: 4 start-page: 1000166 issue: 2 year: 2014 ident: 2167_CR18 publication-title: J Stem Cell Res Ther doi: 10.4172/2157-7633.1000166 – volume: 105 start-page: 2821 issue: 7 year: 2005 ident: 2167_CR57 publication-title: Blood doi: 10.1182/blood-2004-09-3696 – volume: 160 start-page: 223 issue: 3 year: 1990 ident: 2167_CR16 publication-title: J Pathol doi: 10.1002/path.1711600308 – volume: 1011 start-page: 1 year: 2017 ident: 2167_CR21 publication-title: Adv Exp Med Biol doi: 10.1007/978-94-024-1170-6_1 – volume: 2016 year: 2016 ident: 2167_CR89 publication-title: Stem Cells Int – volume: 10 start-page: 753 issue: 11 year: 2010 ident: 2167_CR27 publication-title: Nat Rev Immunol doi: 10.1038/nri2858 – volume: 66 start-page: 352 issue: 2 year: 2017 ident: 2167_CR33 publication-title: Gut doi: 10.1136/gutjnl-2015-309395 – volume: 51 start-page: 21 year: 2018 ident: 2167_CR77 publication-title: Transpl Immunol doi: 10.1016/j.trim.2018.08.004 – volume: 28 start-page: 1856 issue: 10 year: 2010 ident: 2167_CR69 publication-title: Stem Cells doi: 10.1002/stem.503 – volume: 41 start-page: 183 issue: 2 year: 2012 ident: 2167_CR56 publication-title: Immunol Invest doi: 10.3109/08820139.2011.607877 – volume: 24 start-page: 74 issue: 1 year: 2006 ident: 2167_CR48 publication-title: Stem Cells doi: 10.1634/stemcells.2004-0359 – volume: 46 start-page: 1 year: 2013 ident: 2167_CR28 publication-title: J Autoimmun doi: 10.1016/j.jaut.2013.08.006 – volume: 7 start-page: 157 issue: 1 year: 2016 ident: 2167_CR70 publication-title: Stem Cell Res Ther doi: 10.1186/s13287-016-0416-y – volume: 101 start-page: 3722 issue: 9 year: 2003 ident: 2167_CR7 publication-title: Blood doi: 10.1182/blood-2002-07-2104 – volume: 2012 year: 2012 ident: 2167_CR24 publication-title: Int J Hepatol doi: 10.1155/2012/893026 – volume: 27 start-page: 693 issue: 3 year: 2009 ident: 2167_CR51 publication-title: Stem Cells doi: 10.1634/stemcells.2008-0687 – volume: 10 start-page: 401 issue: 2 year: 2015 ident: 2167_CR75 publication-title: Exp Ther Med doi: 10.3892/etm.2015.2551 – volume: 205 start-page: 233 issue: 1 year: 2008 ident: 2167_CR41 publication-title: J Exp Med doi: 10.1084/jem.20072195 – volume: 138 start-page: 124 issue: 2 year: 2013 ident: 2167_CR31 publication-title: Immunology doi: 10.1111/imm.12021 – volume: 33 start-page: 110 issue: 2 year: 2015 ident: 2167_CR32 publication-title: Transpl Immunol doi: 10.1016/j.trim.2015.07.006 – volume: 60 start-page: 1366 issue: 11 year: 1995 ident: 2167_CR45 publication-title: Transplantation – volume: 184 start-page: 3321 issue: 7 year: 2010 ident: 2167_CR26 publication-title: J Immunol doi: 10.4049/jimmunol.0902551 – volume: 18 start-page: 1450 issue: 7 year: 2017 ident: 2167_CR79 publication-title: Int J Mol Sci doi: 10.3390/ijms18071450 – volume: 19 start-page: 1597 issue: 9 year: 2005 ident: 2167_CR59 publication-title: Leukemia doi: 10.1038/sj.leu.2403871 – volume: 8 start-page: 315 issue: 4 year: 2006 ident: 2167_CR5 publication-title: Cytotherapy doi: 10.1080/14653240600855905 – volume: 29 start-page: 601 issue: 5 year: 2018 ident: 2167_CR71 publication-title: Turkish J Gastroenterol doi: 10.5152/tjg.2018.17395 – volume: 12 start-page: 749 issue: 11 year: 2012 ident: 2167_CR23 publication-title: Nat Rev Immunol doi: 10.1038/nri3307 – volume: 92 start-page: 881 issue: 7 year: 2007 ident: 2167_CR63 publication-title: Haematologica doi: 10.3324/haematol.11240 – volume: 41 start-page: 4352 issue: 10 year: 2009 ident: 2167_CR74 publication-title: Transplant Proc doi: 10.1016/j.transproceed.2009.08.072 – volume: 6 start-page: 45 issue: 2 year: 2015 ident: 2167_CR39 publication-title: Int J Organ Transplant Med – volume: 358 start-page: 503 issue: 2 year: 2014 ident: 2167_CR64 publication-title: Cell Tissue Res doi: 10.1007/s00441-014-1956-z – volume: 40 start-page: 1537 issue: 5 year: 2017 ident: 2167_CR87 publication-title: Int J Mol Med doi: 10.3892/ijmm.2017.3121 – volume: 1 start-page: 65 year: 2013 ident: 2167_CR25 publication-title: Annu Rev Anim Biosci doi: 10.1146/annurev-animal-031412-103651 – volume: 50 start-page: 2815 issue: 9 year: 2018 ident: 2167_CR82 publication-title: Transplant Proc doi: 10.1016/j.transproceed.2018.02.180 – volume: 15 start-page: 731 issue: 12 year: 2015 ident: 2167_CR12 publication-title: Nat Rev Immunol doi: 10.1038/nri3920 – volume: 14 start-page: 240 issue: 4 year: 2001 ident: 2167_CR29 publication-title: Transpl Int doi: 10.1111/j.1432-2277.2001.tb00052.x – volume: 262 start-page: 509 issue: 5 year: 2007 ident: 2167_CR9 publication-title: J Intern Med doi: 10.1111/j.1365-2796.2007.01844.x – volume: 29 start-page: 636 issue: 3 year: 2015 ident: 2167_CR67 publication-title: Leukemia doi: 10.1038/leu.2014.225 – volume: 79 start-page: 92 year: 2016 ident: 2167_CR46 publication-title: Mol Immunol doi: 10.1016/j.molimm.2016.10.004 – volume: 2 start-page: 1033 issue: 8151 year: 1979 ident: 2167_CR3 publication-title: Lancet doi: 10.1016/S0140-6736(79)92440-1 – volume: 21 start-page: 216 issue: 2 year: 2014 ident: 2167_CR62 publication-title: Cell Death Differ doi: 10.1038/cdd.2013.158 – volume: 17 start-page: 2 issue: 1 year: 2016 ident: 2167_CR11 publication-title: Nat Immunol doi: 10.1038/ni.3341 – volume: 50 start-page: 1904 issue: 6 year: 2009 ident: 2167_CR38 publication-title: Hepatology doi: 10.1002/hep.23191 – volume: 50 start-page: 612 issue: 2 year: 2009 ident: 2167_CR44 publication-title: Hepatology doi: 10.1002/hep.23043 – volume: 40 start-page: 1022 issue: 4 year: 2010 ident: 2167_CR17 publication-title: Eur J Immunol doi: 10.1002/eji.200939782 – volume: 48 start-page: 8 year: 2017 ident: 2167_CR42 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2017.04.009 – volume: 2 start-page: 141 issue: 2 year: 2008 ident: 2167_CR60 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2007.11.014 – volume: 46 start-page: e70 year: 2014 ident: 2167_CR68 publication-title: Exp Mol Med doi: 10.1038/emm.2013.135 – volume: 10 start-page: 93 year: 2019 ident: 2167_CR15 publication-title: Front Immunol doi: 10.3389/fimmu.2019.00093 – volume: 338 start-page: 1813 issue: 25 year: 1998 ident: 2167_CR30 publication-title: N Engl J Med doi: 10.1056/NEJM199806183382506 – volume: 97 start-page: 1065 issue: 8 year: 2019 ident: 2167_CR8 publication-title: J Mol Med doi: 10.1007/s00109-019-01804-x – volume: 37 start-page: 251 issue: 2 year: 2015 ident: 2167_CR13 publication-title: Alcohol Res – volume: 20 start-page: 187 issue: 1 year: 2012 ident: 2167_CR53 publication-title: Mol Ther doi: 10.1038/mt.2011.189 – volume: 18 start-page: 696 issue: 6 year: 2012 ident: 2167_CR81 publication-title: Liver Transpl doi: 10.1002/lt.23414 – volume: 12 start-page: 708 issue: 6 year: 2015 ident: 2167_CR58 publication-title: Cell Mol Immunol doi: 10.1038/cmi.2014.118 – volume: 59 start-page: 1251 issue: 116 year: 2012 ident: 2167_CR40 publication-title: Hepatogastroenterology – volume: 1 start-page: 10 issue: 1 year: 1995 ident: 2167_CR2 publication-title: Liver Transpl Surg doi: 10.1002/lt.500010104 – volume: 313 start-page: 10 year: 2017 ident: 2167_CR86 publication-title: Cell Immunol doi: 10.1016/j.cellimm.2016.12.006 – volume: 35 start-page: 858 issue: 3 year: 2015 ident: 2167_CR52 publication-title: Cell Physiol Biochem doi: 10.1159/000369743 – volume: 37 start-page: 237 issue: 2 year: 2015 ident: 2167_CR10 publication-title: Alcohol Res – volume: 6 start-page: 2053 issue: 12 year: 2017 ident: 2167_CR72 publication-title: Stem Cells Transl Med doi: 10.1002/sctm.17-0134 – volume: 5 start-page: 970 issue: 12 year: 2012 ident: 2167_CR43 publication-title: Asian Pac J Trop Med doi: 10.1016/S1995-7645(12)60184-9 – volume: 6 start-page: 456 year: 2017 ident: 2167_CR14 publication-title: F1000Research doi: 10.12688/f1000research.11332.1 – volume: 6 start-page: 1348 issue: 12 year: 2000 ident: 2167_CR36 publication-title: Nat Med doi: 10.1038/82161 – volume: 15 start-page: 257 issue: 3 year: 2016 ident: 2167_CR73 publication-title: Hepatobiliary Pancreat Dis Int doi: 10.1016/S1499-3872(16)60085-1 – volume: 111 start-page: 1327 issue: 3 year: 2008 ident: 2167_CR47 publication-title: Blood doi: 10.1182/blood-2007-02-074997 – volume: 52 start-page: 3143 issue: 6 year: 2011 ident: 2167_CR65 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.10-6334 – volume: 74 start-page: 2345 issue: 13 year: 2017 ident: 2167_CR22 publication-title: Cell Mol Life Sci doi: 10.1007/s00018-017-2473-5 – volume: 45 start-page: 1 year: 2017 ident: 2167_CR76 publication-title: Transpl Immunol doi: 10.1016/j.trim.2017.07.005 – volume: 129 start-page: 1628 issue: 7 year: 2009 ident: 2167_CR19 publication-title: J Invest Dermatol doi: 10.1038/jid.2009.30 – volume: 23 start-page: 3449 issue: 19 year: 2017 ident: 2167_CR88 publication-title: World J Gastroenterol doi: 10.3748/wjg.v23.i19.3449 – volume: 41 start-page: 403 issue: 1 year: 2009 ident: 2167_CR83 publication-title: Transplant Proc doi: 10.1016/j.transproceed.2008.10.020 – volume: 5 start-page: 2094 issue: 9 year: 2005 ident: 2167_CR34 publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2005.00995.x – volume: 13 start-page: 149 issue: 1 year: 2015 ident: 2167_CR1 publication-title: Einstein doi: 10.1590/S1679-45082015RW3164 – volume: 177 start-page: 3615 issue: 6 year: 2006 ident: 2167_CR37 publication-title: J Immunol doi: 10.4049/jimmunol.177.6.3615 |
| SSID | ssj0024549 |
| Score | 2.4528797 |
| SecondaryResourceType | review_article |
| Snippet | The liver is supplied by a dual blood supply, including the portal venous system and the hepatic arterial system; thus, the liver organ is exposed to multiple... Abstract The liver is supplied by a dual blood supply, including the portal venous system and the hepatic arterial system; thus, the liver organ is exposed to... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 412 |
| SubjectTerms | Antigen presenting cells Antigens B cells Biomedical and Life Sciences Biomedicine Bone marrow Carcinoma Cell Cell-mediated immunity Cirrhosis Cytokines Cytotoxicity Dendritic cells Graft rejection Hepatocellular carcinoma Hepatocytes Humoral immunity Immune response Immune system Immunological tolerance Immunomodulation Immunoregulation Intestinal microflora Killer cells Liver Liver cancer Liver cirrhosis Liver diseases Liver failure Liver transplantation Liver transplants Lymphocytes Lymphocytes B Lymphocytes T Macrophages Medical prognosis Medicine/Public Health Mesenchymal stem cells Mesenchymal stromal cell Mesenchyme Metabolism Natural killer cells Pathogenic microorganisms Pathogens Patients Prognosis Regulation Rejection Review Stem cell transplantation Stem cells Surgery T cell receptors T cells tissue and gene therapy Tumor necrosis factor-TNF |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR3LbtQw0IKCEBfej0BBRkLiAFGdOHHiEyqIigNUHHrYm-VMHBppmyybLaJ_z4zj7JIieuEWxQ9lMm97Hoy9hrrWKVQ2rq2U6KCAjkstXAwSnZVGpGCdx_SX4vi4XCz0t3DgNoSwykkmekFd90Bn5Aeo-UtFBZqS96sfMXWNotvV0ELjOrtBbbOJzovFzuHK0PmZEmVKdTCgblMUaKlj1Gz0NFNGvmb_35L5D9V0OWzy0t2pV0lHd_8XmHvsTjBG-eFIPffZNdc9YLe-huv2h-wXEhFvKYOkX4896xGLvG_4GeUswenFGa6mStCczv8Hvlrai4FbDqF_AqfYRd52uEc4uuBob3KKCev6oR1oqyUFhvCNr7G-tGMiVPeInRx9Ovn4OQ6tGmJQotjEtbSZBAEFJNYlKnfI1pW0TS4qLZTTTjTI6ykotE4ESFWi4wRWVWhM5XVq5WO21_Wde8q4S6o8s9K5xNZZXWYoIFyTVTZPbQVV6SKWTCgzEMqYUzeNpfHuTKnMiGaDaDYezUZE7O12zWos4nHl7A9ECduZVIDbv-jX303gZ5NqtLREAoACMNNFWjU2sRnuZatc1EUesTdER4bEBH4e2JDtgEBSwS1zqKi_W4J8EbH92Uxkb5gPTyRkgngZzI5-IvZqO0wrKWSuc_25n5NpdO9LHbEnI-FuQUJBnsqizCJWzEh6BvN8pGtPffFxpamCkIzYu4n4d5_173_67GoonrPbKbFlkqJZsM_2Nutz94LdhJ-bdli_9Ez9Gz5jVSE priority: 102 providerName: ProQuest – databaseName: SpringerLINK Contemporary 1997-Present dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9UwELagIMSFfQkUZCQkDhBhx4ljHwui4gAVggr1ZjkTp33Sa1K9vCL675lxkldSFgluUbwotmeNZ75h7DnUtc2g8mntlUIHBWxqrAgpKHRWGpGBD_GkP5R7e-bgwH4ak8L6Kdp9upKMkjqytdGve9RMmsIkbYp6iZ4usyuo7gwVbPj85es5wh66PFN6zG_HzVRQROr_VR7_pJAuBkteuDGNimj35v8t4Ra7MRqefGeglNvsUmjvsGsfx6v1u-w7EgxfULZItxrq0-OJ8a7hx5SfBEdnxziaUJ85_evv-cnSn_XccxhrJXCKU-SLFucYf1NwtC05xX-1Xb_oaaolBYHwdcRTX_oh6am9x_Z33-2_fZ-OZRlS0KJcp7XyuQIBJUgfpC4CsnClfFOIygodbBAN8nUGGi0RAUobdJLA6woNp6LOvLrPttquDQ8ZD7Iqcq9CkL7Oa5OjMAhNXvki8xVUJiRMTgflYIQsp8oZSxddF6PdsKMOd9TFHXUiYS83Y04GwI6_9n5D57_pSWDb8UW3OnQj77rMIpkJCYDCLrdlVjVe-hzn8lUh6rJI2AuiHkciAT8P_JjZgIskcC23o6mWm0QeSNj2rCeyMsybJ_pzoyjpHZq8RhMymUzYs00zjaTwuDZ0p7FPbtGVNzZhDwZy3SwJhXamSpMnrJwR8mzN85Z2cRSBxrUltCCVsFcTOZ9_1p_39NG_dX_MrmfEETJDk2Cbba1Xp-EJuwrf1ot-9TSy9g9njktN priority: 102 providerName: Springer Nature |
| Title | The immunoregulation of mesenchymal stem cells plays a critical role in improving the prognosis of liver transplantation |
| URI | https://link.springer.com/article/10.1186/s12967-019-02167-0 https://www.ncbi.nlm.nih.gov/pubmed/31823784 https://www.proquest.com/docview/2328697811 https://www.proquest.com/docview/2324921189 https://pubmed.ncbi.nlm.nih.gov/PMC6905033 https://doaj.org/article/2950901cc4884972bfa1a4129ab50d75 |
| Volume | 17 |
| WOSCitedRecordID | wos000517754200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central Open Access Free customDbUrl: eissn: 1479-5876 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0024549 issn: 1479-5876 databaseCode: RBZ dateStart: 20030101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1479-5876 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0024549 issn: 1479-5876 databaseCode: DOA dateStart: 20030101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1479-5876 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0024549 issn: 1479-5876 databaseCode: M~E dateStart: 20030101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1479-5876 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0024549 issn: 1479-5876 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1479-5876 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0024549 issn: 1479-5876 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content Database customDbUrl: eissn: 1479-5876 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0024549 issn: 1479-5876 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLink Contemporary customDbUrl: eissn: 1479-5876 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0024549 issn: 1479-5876 databaseCode: RSV dateStart: 20030601 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwED_BQIiXic-RMSojIfEA0Zw4ceLHDW0CiVXVmFB5shzH0SJ16dR0iP333DlJWYaAF16qJj5H9n34fMn5dwBvbFmq2BYmLI0QGKBYFeaKu9AKDFYqHlvjvKQ_Z9NpPp-r2Y1SX5QT1sEDd4zbjxW6NB5Zi5qWqCwuKhOZBL2UKVJeZh69lGdqCKYGlD0Me4YjMrncb5FeUoqlCtGn0b-RG_Jo_b-vyTec0u2EyVtfTb0zOn4E2_0ukh10o38Md1zzBB6c9N_Jn8IPlD6r6ejHctUVm0f2s2XFLuiwkT2_vsDeBOHM6MV9yy4X5rplhtm-8AGjpENWN_iM_p0Dw40io2SuZtnWLT1qQRkdbO3B0RemO8HUPIOz46OzDx_DvsZCaCXP1mEpTCIst5mNjItk6tAeC2GqlBeKS6ccr9BIYytxW8GtkDlGPNbIAndBaRkb8Ry2mmXjXgBzUZEmRjgXmTIpUVZSuCopTBqbwha5CyAaOK5tjz9OZTAW2schudSdlDRKSXspaR7Au02fyw5946_UhyTIDSUhZ_sbqE-61yf9L30K4C2pgSb7xuFZ0x9TwEkSUpY-kFSYLUKFDmBvRIl2acfNgyLpfl1oNe5fc0kwY1EArzfN1JNy3Rq3vPI0icK4PFcB7HR6t5kSrsCxyPIkgGykkaM5j1ua-tyjhktF0D8igPeD7v4a1p95uvs_ePoSHsZke1GMXn8PttarK_cK7tvv67pdTeBuNs_8bz6Be4dH09npxFszXs0-ncy-4dXpl68_Ae1CTDo |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VgoALb6ihwCKBOIBVe22vvQeEyqNq1TTikENuq_V63UZK7TROgfwo_iMzfiS4iN564BbFuyuP_c03O955ALw2WSa5SbWb6SBAB8VIN5GedU2AzkrucaNt_aYH8XCYjMfy2wb86nJhKKyy48SaqLPS0DfyHbT8iaACTf7H2ZlLXaPodLVrodHA4tAuf6DLVn04-ILv9w3ne19Hn_fdtquAa4QXL9ws0GFgPBMbX1tfRBYRmAY6j7xUesJK6-UIS24EGlLPBCLBPb7RIkW7H2VcB7jsNbiONB6TrxeP1_5diL5Wl5eTiJ0KTamguE7poiGlXz3bV7cI-NsQ_GEJL0ZpXjiqrS3g3t3_7NndgzvtVpvtNrpxHzZs8QBuHrXBBA_hJ6oIm1B-TDm3x20bM1bm7JQysszJ8hRnU51rRqcbFZtN9bJimpm2OwSjyEw2KXCN9sMMw900o4i3oqwmFS01pbAXtqgryE91k-ZVPILRVYj9GDaLsrBbwKyfRqEOrPV1FmZJiPRn8zDVEdepSRPrgN8hRJm2SDv1Cpmq2llLhGpQpRBVqkaV8hx4t5oza0qUXDr6EwFvNZLKi9d_lPNj1bKV4hL3kZ5vDNJ7KGOe5trXIa6l08jL4siBtwRbRSSIt2d0m8uBQlI5MbUrqHudj1rvwHZvJJKX6V_uEKta8qzUGq4OvFpdppkUEFjY8rweE0qOMkoHnjR6shIJzRQP4iR0IO5pUE_m_pViclKXVheS6iMFDrzvdG19W_9-pk8vl-Il3NofHQ3U4GB4-Axuc2IEn-MGaBs2F_Nz-xxumO-LSTV_UfMJA3XFOvgbfSCv0Q |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9QwDLdgoImX8TkoDAgSEg9QLW3atHkcHycQ4zSJCe0tStOUnXRrT9duYv89dtq7reNDQrxVjRM1ie3Yjf0zwEtbliq2hQlLIwQ6KFaFueIutAKdlYrH1ji_0_vZdJofHamDS1n8Ptp9dSXZ5zQQSlPd7S7KqhfxXO62eEpJCplUIZ5R9HQdbiQUSE_--tdvF2h76P6sUmV-2290HHnU_l9186XD6Wrg5JXbU38oTW7__3TuwNZgkLK9noPuwjVX34PNL8OV-334gYzEZpRF0iz7uvW4k6yp2AnlLdnj8xPsTWjQjO4AWraYm_OWGWaHGgqM4hfZrMYxht8XDG1ORnFhddPOWhpqTsEhrPM463PTJ0PVD-Bw8uHw3cdwKNcQWsmzLiyFSYTlNrORcZFMHYp2IUyV8kJx6ZTjFcp7bCVaKNwKmaPzZI0s0KBKy9iIbdiom9o9AuaiIk2McC4yZVLmCSoJVyWFSWNT2CJ3AUSrTdN2gDKnihpz7V2aXOp-RTWuqPYrqnkAr9d9Fj2Qx1-p3xIvrCkJhNu_aJbf9SDTOlZobfHIWlSCicriojKRSXAsU6S8zNIAXhEnaVIV-HnWDBkPOEkC3dJ7kmq8RSgbAeyMKFHE7bh5xYt6UDGtRlM4l4RYFgXwYt1MPSlsrnbNqadJFLr4uQrgYc-66ymhMo9FlicBZCOmHs153FLPjj0AuVSEIiQCeLNi7YvP-vOaPv438uewefB-ovc_TT8_gVsxCUcUo9WwAxvd8tQ9hZv2rJu1y2de4n8Cf65XFQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+immunoregulation+of+mesenchymal+stem+cells+plays+a+critical+role+in+improving+the+prognosis+of+liver+transplantation&rft.jtitle=Journal+of+translational+medicine&rft.au=Hu%2C+Chenxia&rft.au=Li%2C+Lanjuan&rft.date=2019-12-10&rft.pub=BioMed+Central&rft.eissn=1479-5876&rft.volume=17&rft_id=info:doi/10.1186%2Fs12967-019-02167-0&rft_id=info%3Apmid%2F31823784&rft.externalDocID=PMC6905033 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1479-5876&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1479-5876&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1479-5876&client=summon |